In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare ...

BioMarin Pharmaceutical had a net margin of 14.96% and a return on equity of 9.91%. Sell-side analysts expect that BioMarin Pharmaceutical Inc. will post 3.15 earnings per share for the current year.

(RTTNews) - Biomarin Pharmaceutical Inc. (BMRN) announced a profit for its fourth quarter that increased from the same period last year and beat the Street estimates. The company's earnings ...